Athira Pharma Stock Momentum Indicators Balance Of Power

ATHA Stock  USD 0.58  0  0.69%   
Athira Pharma momentum indicators tool provides the execution environment for running the Balance Of Power indicator and other technical functions against Athira Pharma. Athira Pharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the Balance Of Power indicator function is designed to identify and follow existing trends. Momentum indicators of Athira Pharma are pattern recognition functions that provide distinct formation on Athira Pharma potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations.

Indicator
The output start index for this execution was zero with a total number of output elements of sixty-one. The Balance Of Power measures the strength of Athira Pharma market sensitivity to bulls and bears. It estimates the ability of Athira Pharma to push price to an extreme high or extreme low level. As a result, by monitoring Athira Pharma Balance of Power indicator one can determine a trend of the price direction

Athira Pharma Technical Analysis Modules

Most technical analysis of Athira Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Athira from various momentum indicators to cycle indicators. When you analyze Athira charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Athira Pharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Athira Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Athira Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Athira Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Athira Pharma's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Athira Pharma's intrinsic value. In addition to deriving basic predictive indicators for Athira Pharma, we also check how macroeconomic factors affect Athira Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Current Ratio28.079.685.375.1
Net Debt To EBITDA2.00.990.760.72
Hype
Prediction
LowEstimatedHigh
0.030.638.30
Details
Intrinsic
Valuation
LowRealHigh
0.112.279.94
Details
Naive
Forecast
LowNextHigh
0.010.618.28
Details
4 Analysts
Consensus
LowTargetHigh
6.677.338.14
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Athira Pharma. Your research has to be compared to or analyzed against Athira Pharma's peers to derive any actionable benefits. When done correctly, Athira Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Athira Pharma.

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Athira Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Athira Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Athira Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Athira Pharma Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Athira Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For information on how to trade Athira Stock refer to our How to Trade Athira Stock guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Athira Pharma. If investors know Athira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Athira Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.84)
Return On Assets
(0.48)
Return On Equity
(0.85)
The market value of Athira Pharma is measured differently than its book value, which is the value of Athira that is recorded on the company's balance sheet. Investors also form their own opinion of Athira Pharma's value that differs from its market value or its book value, called intrinsic value, which is Athira Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Athira Pharma's market value can be influenced by many factors that don't directly affect Athira Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Athira Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Athira Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Athira Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.